These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30278162)

  • 1. Mechanistic studies on the effect of membrane lipid acyl chain composition on daptomycin pore formation.
    Beriashvili D; Taylor R; Kralt B; Abu Mazen N; Taylor SD; Palmer M
    Chem Phys Lipids; 2018 Nov; 216():73-79. PubMed ID: 30278162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daptomycin Pore Formation Is Restricted by Lipid Acyl Chain Composition.
    Taylor R; Beriashvili D; Taylor S; Palmer M
    ACS Infect Dis; 2017 Nov; 3(11):797-801. PubMed ID: 29048870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two successive calcium-dependent transitions mediate membrane binding and oligomerization of daptomycin and the related antibiotic A54145.
    Taylor R; Butt K; Scott B; Zhang T; Muraih JK; Mintzer E; Taylor S; Palmer M
    Biochim Biophys Acta; 2016 Sep; 1858(9):1999-2005. PubMed ID: 27237728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiolipin prevents membrane translocation and permeabilization by daptomycin.
    Zhang T; Muraih JK; Tishbi N; Herskowitz J; Victor RL; Silverman J; Uwumarenogie S; Taylor SD; Palmer M; Mintzer E
    J Biol Chem; 2014 Apr; 289(17):11584-11591. PubMed ID: 24616102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of daptomycin oligomerization with perylene excimer fluorescence: stoichiometric binding of phosphatidylglycerol triggers oligomer formation.
    Muraih JK; Harris J; Taylor SD; Palmer M
    Biochim Biophys Acta; 2012 Mar; 1818(3):673-8. PubMed ID: 22079564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daptomycin forms cation- and size-selective pores in model membranes.
    Zhang T; Muraih JK; MacCormick B; Silverman J; Palmer M
    Biochim Biophys Acta; 2014 Oct; 1838(10):2425-30. PubMed ID: 24857935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular State of the Membrane-Active Antibiotic Daptomycin.
    Lee MT; Hung WC; Hsieh MH; Chen H; Chang YY; Huang HW
    Biophys J; 2017 Jul; 113(1):82-90. PubMed ID: 28700928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The action mechanism of daptomycin.
    Taylor SD; Palmer M
    Bioorg Med Chem; 2016 Dec; 24(24):6253-6268. PubMed ID: 27288182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutual inhibition through hybrid oligomer formation of daptomycin and the semisynthetic lipopeptide antibiotic CB-182,462.
    Zhang T; Muraih JK; Mintzer E; Tishbi N; Desert C; Silverman J; Taylor S; Palmer M
    Biochim Biophys Acta; 2013 Feb; 1828(2):302-8. PubMed ID: 23084999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Acyl-Linked Dimer of Daptomycin Is Strongly Inhibited by the Bacterial Cell Wall.
    Taylor RM; Scott B; Taylor S; Palmer M
    ACS Infect Dis; 2017 Jul; 3(7):462-466. PubMed ID: 28350438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysyl-phosphatidylglycerol attenuates membrane perturbation rather than surface association of the cationic antimicrobial peptide 6W-RP-1 in a model membrane system: implications for daptomycin resistance.
    Kilelee E; Pokorny A; Yeaman MR; Bayer AS
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4476-9. PubMed ID: 20660664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daptomycin-Phosphatidylglycerol Domains in Lipid Membranes.
    Kreutzberger MA; Pokorny A; Almeida PF
    Langmuir; 2017 Nov; 33(47):13669-13679. PubMed ID: 29130685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthesis and genetic engineering of lipopeptide antibiotics related to daptomycin.
    Baltz RH
    Curr Top Med Chem; 2008; 8(8):618-38. PubMed ID: 18473888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligomerization of daptomycin on membranes.
    Muraih JK; Pearson A; Silverman J; Palmer M
    Biochim Biophys Acta; 2011 Apr; 1808(4):1154-60. PubMed ID: 21223947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of multimeric daptomycin bound to lipid nanodiscs formed by calcium-tolerant styrene-maleic acid copolymer.
    Beriashvili D; Spencer NR; Dieckmann T; Overduin M; Palmer M
    Biochim Biophys Acta Biomembr; 2020 Jun; 1862(6):183234. PubMed ID: 32145282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing the Structure-Activity Relationship between Phosphatidylglycerol and Daptomycin.
    Moreira R; Taylor SD
    ACS Infect Dis; 2022 Aug; 8(8):1674-1686. PubMed ID: 35793519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating Daptomycin's Antibacterial Efficacy: Insights into the Tripartite Complex with Lipid II and Phospholipids in Bacterial Septum Membrane.
    Srivastava D; Patra N
    J Phys Chem B; 2024 May; 128(18):4414-4427. PubMed ID: 38690887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of the subunit stoichiometry of the membrane-associated daptomycin oligomer by FRET.
    Muraih JK; Palmer M
    Biochim Biophys Acta; 2012 Jul; 1818(7):1642-7. PubMed ID: 22387459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding Studies Reveal Phospholipid Specificity and Its Role in the Calcium-Dependent Mechanism of Action of Daptomycin.
    Kotsogianni I; Wood TM; Alexander FM; Cochrane SA; Martin NI
    ACS Infect Dis; 2021 Sep; 7(9):2612-2619. PubMed ID: 34406007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid membrane-binding properties of daptomycin using surface plasmon resonance.
    Kinouchi H; Onishi M; Kamimori H
    Anal Sci; 2013; 29(3):297-301. PubMed ID: 23474718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.